Gut Microbiota for Health World Summit - Washington 2021
PAST EDITIONS

Program
2023 GMFH Summit

All times are in local time – CET

General Topic: “The next generation of microbiome-based therapy and nutrition”

Saturday, March 11

8:15 – 8:30 am
Welcome and Day 1 Kickoff
Harry Sokol (Paris, France)

8:30 – 9:00 am
Keynote Lecture:
The bright future of next generation microbiome-based therapy
Eugene B. Chang (Chicago, USA)

PLENARY SESSION 1:
Next generation probiotics: single strains and consortia

Session Moderator: Giovanni Barbara (Bologna, Italy)

9:00 – 9:30 am
Commensal Clostridiales strains mediate effective anti-cancer immune response against solid tumors
Michael Scharl (Zurich, Switzerland)

9:30 – 10:00 am
F. prausnitzii as a potential LBP to boost immune checkpoint inhibitors efficacy
Harry Sokol (Paris, France)

10:00-10:30 am
Probiotic to accelerate gut microbiome maturation in extremely preterm infants
Marie-Claire Arrieta (Calgary, Canada) 

10:30 – 11:00 am
Morning Break

PLENARY SESSION 2:
Fecal Microbiota Transplantation

Session Moderator: Colleen R. Kelly (Providence, USA)

11:00 – 11:30 am
Efficacy of FMT: does engraftment matters?
Gianluca Ianiro (Rome, Italy)

11:30 – 12:00 pm
FMT in Ulcerative colitis
Rupert W. Leong, (Sydney, Australia)

12:00 – 12:30 pm
FMT with Fibers supplementation in metabolic syndrome and obesity
Karen L. Madsen, (Alberta, Canada)

12:30 – 02:00 pm
Networking Lunch


WORKSHOPS SESSIONS

02:00 – 03:30 pm
WORKSHOPS 1A, 2A, 3A AND 4A

1A. Engineered microorganisms as therapeutic agents
Moderator: R. Balfour Sartor (Chapel Hill, USA)

  • Engineered probiotics for local tumor delivery of anti cancer treatment
    Nicholas Arpaia (New York, USA)
  • Engineered probiotics to deliver therapeutic proteins
    Jan Peter van Pijkeren (Madisson, USA)

2A. Targetting the gut microbiota in Liver Diseases
Moderator: Robert F. Schwabe (New York, USA)

  • Editing the gut microbiota as therapeutic strategy for liver disease
    Bernd Schnabl (San Diego, USA)
  • Prebiotics and probiotics to target the gut microbiota in liver disease: a concept that needs updating
    Anne-Marie Cassard Doulcier (Paris, France)

3A. Detrimental effects of western diet on gut microbiota-mucus interaction
Moderator: Francisco Guarner (Barcelona, Spain)

  • Food additive
    Benoit Chassaing (Paris, France)
  • Genetic adaptation of keystone species
    Tanja Dapa (Sevilla, Spain)

4A. The gut-brain axis as a therapeutic target
Moderator: Emeran Mayer (Los Angeles, USA)

  • Intersections of the microbiota and the central nervous system
    Helen Vuong (Minneapolis, USA)
  • Gut bacteria: a novel treatment for neuropsychiatric disorders?
    Premysl Bercik (Hamilton, Canada)


03:30 – 04:00 pm
Poster session

 04:00 – 05:30 pm
WORKSHOPS 1B, 2B, 3B AND 4B

1B. Engineered microorganisms as therapeutic agents
Moderator: R. Balfour Sartor (Chapel Hill, USA)

  • Engineered probiotics for local tumor delivery of anti cancer treatment
    Nicholas Arpaia (New York, USA)
  • Engineered probiotics to deliver therapeutic proteins
    Jan Peter van Pijkeren (Madisson, USA)

2B. Targetting the gut microbiota in Liver Diseases
Moderator: Robert F. Schwabe (New York, USA)

  • Editing the gut microbiota as therapeutic strategy for liver disease
    Bernd Schnabl (San Diego, USA)
  • Prebiotics and probiotics to target the gut microbiota in liver disease: a concept that needs updating
    Anne-Marie Cassard Doulcier (Paris, France) 

3B. Detrimental effects of western diet on gut microbiota-mucus interaction
Moderator: Francisco Guarner (Barcelona, Spain)

  • Food additive
    Benoit Chassaing (Paris, France)
  • Genetic adaptation of keystone species
    Tanja Dapa (Sevilla, Spain)

4B. The gut-brain axis as a therapeutic target
Moderator: Emeran Mayer (Los Angeles, USA)

  • Intersections of the microbiota and the central nervous system
    Helen Vuong (Minneapolis, USA)
  • Gut bacteria: a novel treatment for neuropsychiatric disorders?
    Premysl Bercik (Hamilton, Canada)

05:30 – 07:00 pm
Networking Reception

Sunday, March 12

08:15 – 08:20 am
Kickoff
Gail Hecht (Chicago, USA)

PLENARY SESSION 3:
Diet and Prebiotics

Session Moderator: Joel Doré (Paris, France)

08:20 – 08:50 am
Manipulating dietary fibers and host mucus
Mahesh S. Desai (Luxembourg) 

08:50 – 09:20 am
Gut-microbiota-targeted diets modulate human immune status
Matthew Carter (Stanford, USA)

09:20 – 09:50 am
Dietary fibers and response to immune checkpoint inhibitors
Meriem Messaoudene (Montreal, Canada)

09:50 – 10:20 am
Diet OMICS – understanding how different diet affect bacterial metabolism
Yael Haberman (Tel-Aviv, Israel)

10:20 – 10:50 am
Morning Break

 

PLENARY SESSION 4:
Microbiota derived molecules

Session Moderator: Gary D. Wu (Philadelphia, USA)

10:50 – 11:50 am
Bacterial sensing via neuronal Nod2 regulates appetite and body temperature.
Pierre-Marie Lledo (Paris, France)

11:50 – 12:20 pm
Microbial biotin and obesity
Karine Clément (Paris, France)

12:20 – 12:50 pm
Short chain fatty acid as modulator of gamma delta T cells function
Marie-Laure Michel (Paris, France)

12:50 – 01:00 pm
Closing remarks
Harry Sokol (Paris, France) & Gail Hecht (Chicago, USA)

01:00 pm
Lunch for All Attendees